Government Interviewing Pharmaceutical 
Mad in America
DECEMBER 20, 2023
For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Listen to the audio of the interview here. Was it related to medical insurance or government programs? Does pharma take the same approach, do you believe?
Work Life
SEPTEMBER 24, 2024
With Ignition Schools, we’re formalizing the analysis of the colleges and universities where some of the world’s greatest ideas originate, using metrics such as the number of venture-backed companies founded by students and alumni, the total venture money raised by students and alumni, and government research and development expenditures.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
DECEMBER 13, 2023
You sent some great questions and on this and our next podcast, we will be talking with Bob about Mad in America, the biopsychosocial model, the history of psychiatry, pharmaceutical marketing, and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Listen to the audio of the interview here.
Mad in America
OCTOBER 18, 2023
Listen to the audio of the interview here. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are.
Mad in America
AUGUST 21, 2024
I n this interview for MIA Radio, Brooke Siem speaks with David Taylor and Mark Horowitz about their publication of the Maudsley Deprescribing Guidelines, which is of particular note since the Maudsley Prescribing Guidelines is a leading text in medicine worldwide. Listen to the audio of the interview here. Who’s Maudsley?
Workplace Insight
DECEMBER 14, 2023
It is striking how weighted Ireland’s export figures are to the life sciences, medical and pharmaceutical industries craved by the UK Just how significant is apparent when comparing the UK with Ireland.
Inside Workplace Wellness
AUGUST 1, 2018
The demise of the CMS deal illustrates how difficult it is to figure out how much government health programs should pay for expensive treatments whose long-term benefits are still unclear. Does your PBM require providers to use NDC coding for Specialty Pharmaceuticals to improve monitoring and tracking of utilization?
Expert insights. Personalized for you.
144 
Let's personalize your content